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 i 
ABSTRACT 
 
 Previous research has proposed that the somatosensory feedback generated 
during exercise is a key component in regards to the mechanism underlying the 
therapeutic effects of exercise on the motor symptoms of Parkinson’s disease (PD). 
This thesis aimed to further examine the contributions of different forms of 
somatosensory feedback during exercise in PD in order to understand the mechanism 
for symptom improvements that certain exercise studies report. 
 This randomized, controlled exercise study consisted of three treadmill 
groups, with the RATE and MAGNITUDE groups serving as the experimental 
conditions, while the CONTROL condition was an active comparator treadmill 
walking group.  The RATE group attempted to elicit a rapid sampling rate from 
somatosensory afferents by having participants walk at a high cadence. The 
MAGNITUDE group attempted to generate a signal from somatosensory receptors 
that was larger or richer in magnitude by having participants wear ankle weights with 
the premise that the additional weight would cause tension sensitive golgi tendon 
organs to increase signaling. The CONTROL treadmill group served as an active 
comparator control group where participants walked regularly.  Each condition 
finished with 13 participants with idiopathic PD.  
 All treadmill groups trained at the same aerobic intensity, duration, and 
frequency. however, only the RATE group improved in  the primary outcome 
measure (motor section of the Unified Parkinson’s Disease Rating Scale (UPDRS-
III)) after exercise. Furthermore, this same condition improved on the upper limb 
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score of the UPDRS-III, possibly indicative of an overall improvement in basal 
ganglia (BG) functioning.  Main effects of time were reported for step length in 
velocity across all treadmill training groups during both self-paced and maximal 
walking speeds.  No changes in any measures of postural control were detected.   
 This study demonstrates that exercise that generates a high rate of 
somatosensory feedback from appears to be the most capable of improving motor 
symptoms of PD.  Furthermore, gait improvements from treadmill training were 
independent of improvements in UPDRS-III, and are likely an effect of motor 
learning.  
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PROBLEM STATEMENT 
 Studies examining exercise interventions for the treatment of the motor 
symptoms in PD have been popular in the last decade, as the need for complementary 
strategies to pharmaceutical treatment has become more apparent.  However, despite 
the body of research that has been conducted on exercise and PD, the actual 
mechanism(s) responsible for the therapeutic effect of that remain largely unknown.  
Furthermore, due to the lack of randomized, controlled exercise studies, current 
evidence of exercise as a reliable rehabilitation method remains limited.  
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Chapter 1: Prologue 
AN OVERVIEW OF PARKINSON’S DISEASE 
Parkinson’s disease (PD) is a progressive neurological disorder that manifests 
when a substantial amount of dopaminergic neurons in the basal ganglia (BG) have 
died. Prevalence over the age of 70 is approximately 1 in 100, making PD the second 
most common neurodegenerative disease second only to Alzheimer’s (Pringsheim, 
Jette, Frolkis & Steeves, 2014). Symptoms of PD are widespread, and are classified 
into motor and non-motor categories.  Motor symptoms include tremor, bradykinesia, 
rigidity, postural instability, impaired gait, and poor proprioception (Guttman, Kish, 
& Furukawa, 2003; Rocchi, Chiari, & Horak, 2012; Schaafsma et al., 2003). Non-
motor symptoms include, but are not limited to; mood disturbances, digestive 
complications, and autonomic system dysfunction (Park & Stacy, 2009).  Symptoms 
worsen in severity as the disease progresses, eventually leading to loss of 
independence and a reduced quality of life.  
Although there is not yet a cure for PD, treatment options do exist. Dopamine 
replacement therapy (DRT) consisting of the synthetic dopamine precursor Levodopa 
(L-DOPA) is the most common and accessible method for managing the motor 
symptoms of the disease (Sprenger & Poewe, 2013).  Although the drugs ameliorate 
the symptoms, their use is associated with several unpleasant side effects such as 
dyskinesias, orthostatic hypotension, hallucinations, and on/off fluctuation (Fahn, 
1996).  Also of importance is the diminished therapeutic effect after prolonged usage 
as well as its possibility to be toxic to remaining dopaminergic neurons (Fahn, 1996; 
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Fahn et al. 2004).  Furthermore, postural instability and gait dysfunction do not 
respond well to dopaminergic medication, leaving the two symptoms that are 
associated with the highest morbidity in PD mainly untreated (Sethi, 2008; Hely, 
Morris, Reid, & Trafficante, 2005). Thus, the value of determining if alternative 
treatment methods such as exercise are capable of improving these symptoms is 
important for the development of an ideal motor symptom improvement strategy.   
The gold standard for assessing motor symptom severity is the motor section 
of the Unified Parkinson’s Disease Rating Scale (UPDRS-III), which is a battery of 
14 tests performed by a trained assessor (Movement Disorder Society Task Force on 
Rating Scales for Parkinson’s Disease, 2003).  Each test is scored on a scale from 0-4, 
with 0 representing normal or no impairment, and 4 representing extreme 
impairment/inability to perform the task.  Although the test is subjective, the UPDRS 
III demonstrates high reliability and validity across all severities and is a universally 
accepted rating scale for patients with PD (Movement Disorder Society Task Force 
on Rating Scales for Parkinson’s Disease, 2003).  The UPDRS-III is designed to 
assess the cardinal symptoms of PD: bradykinesia (slowness), postural instability and 
gait dysfunction, tremor, and akinesia (difficulty initiating movement). New 
pharmaceutical treatments are also assessed with the UPDRS-III (Jones & Murray 
2014).  If exercise should be considered worthy of prescription by medical 
practitioners as a complementary or alternative therapy, the efficacy of exercise to 
improve motor symptoms should be measured on the same scale to allow for a direct 
comparison.  
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EXERCISE AS THERAPY FOR THOSE WITH PD 
Exercise has been shown to improve the condition of several chronic diseases 
and promote good health in general (Mattson, 2000; Haskell et al., 2007).   Naturally, 
the efficacy of exercise and physical activity to improve the motor symptoms of PD 
has been a popular area of research in recent years.  However, despite the amount of 
research that has been conducted, fundamental questions about what specific forms of 
exercise are therapeutic for PD, and more importantly the mechanisms behind the 
therapeutic benefits remain largely unanswered. A more thorough understanding of 
which specific types of exercise are most efficacious will allow health practitioners to 
prescribe more successful exercise therapy for those with PD.   Specifically, 
understanding the actual traits (frequency, intensity, type and time) of exercise that 
provide motor symptom relief allows for more knowledge based exercise 
prescription.   
EXERCISE AND ANIMAL MODELS OF PD 
Initial studies involving exercise and Parkinson’s disease have utilized rodent 
models which use either 6-hydroxydopamine (6-OHDA) or 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP) as toxic agents. These agents act selectively on 
DA producing neurons, providing a reliable model to examine how exercise affects 
the dopaminergic system.  Lau et al. (2011) examined the effects of a continuous 
treadmill based aerobic program in an MPTP rat model with aims to shed light on the 
exact mechanisms responsible for exercise-induced neuroprotection.  Rats that 
exercised improved the function of nigrostriatal neurons, determined by synaptic 
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dopamine (DA) levels and dopamine active transporter (DAT) activity.  An 
upregulation of neurotrophic factors such as brain-derived neurotrophic factor 
(BDNF) and Glial-derived neurotrophic factor (GDNF) were also noted, and has been 
reported in other works involving rat models (Tillerson, Caudle, Reveron & Miller, 
2003).  
Results from exercise in animal models of PD shed light upon the neural 
changes that may be responsible for motor symptom relief.  It remains unclear if 
benefits from exercise and physical activity experienced in humans with PD can be 
attributed to these same factors, however, human studies examining acute bouts of 
aerobic exercise have shown an increase in synaptic DA concentration immediately 
after exercise (Wang et al., 2000).  Although examining DA function is outside the 
scope of this thesis, animal models provide insight to the exercise derived neural 
changes responsible for symptom improvement. 
EXERCISE IN HUMAN POPULATIONS WITH PD 
Several modalities of exercise have been tested in human models of PD with 
mixed results.  It appears that only certain forms of exercise are capable of providing 
post treatment reductions in UPDRS-III scores. Interventions that lead to reductions 
in overall UPDRS-III scores should be considered more successful than those that 
lead to improvements in an outcome measure that is similar to the training protocol.  
This is because improvements in UPDRS-III scores may be more indicative of 
improvements in the BG network (, rather than an improvement that can be explained 
by practice or motor control theories. 
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i. Treadmill based exercise 
A variety of treadmill training (TT) interventions have been studied within the 
PD population comprising of varying intensities, speeds, and the use of body weight 
supported treadmill training (BWSTT).  Benefits are dependent upon the actual type 
of TT intervention, but overall have shown to be a promising rehabilitative strategy 
for those with PD.  
 Fisher examined varying intensities of BWSTT with patients in early stages of 
PD.  Patients in the high intensity group were trained at 75% of their age adjusted 
maximum heart rate (AAMHR), determined by the Karvonen formula (220-age).   
The low intensity group was trained at no greater than 50% of their AAMHR, and the 
zero intensity group attended educational sessions.  The exercise based groups trained 
for 24 sessions over 8 weeks, while the zero intensity education group attended 4 
separate information sessions.  Outcome measures included the UPDRS III, self-
selected and fast paced gait analysis, and a cortical excitability measure derived from 
transcranial magnetic stimulation (TMS). A slight, but non-significant improvement 
was reported in the UPDRS III. Significant improvements in spatiotemporal measures 
of gait including step length (1.48m to 1.56m, p<.05) and in both self-selected 
(1.46m/s to 1.52m/s, p<.05) and fast paced (1.91m/s to 2.00m/s, p<.05) walking 
velocities.  Cortical excitability, determined by a TMS based cortical silent period 
(CSP) improved to levels that were closer to age-matched control participants, 
however, only in the high intensity training group. The authors attributed the 
improvements in cortical excitability to a possible upregulation of neurotrophic 
factors as a result of high intensity exercise. This study did not report average 
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walking speed or cadence of the actual training sessions, since maintaining a 
percentage of AAMHR was the main objective during training sessions. 
Miyai et al. examined the effects of BWSTT in comparison to a traditional, 
gait based physiotherapy (PT) intervention not involving treadmill use. This study 
sampled moderately severe PD participants, and it was proposed that the body weight 
support (BWS) would allow them to train with a more proper gait pattern. The 
authors proposed that the proper gait pattern leads to a higher quality of afferent 
somatosensory feedback being sent to the CNS. The study was a crossover with the 
sample (n=10) being equally split into 4 weeks of each condition with 5 participants 
receiving BWSTT first, and 5 receiving traditional PT first.  The BWSTT condition 
consisted of 12 sessions each lasting 45 minutes including 9 minutes of rest time.  
Body weight support was adjusted throughout each session starting with 20% for 12 
minutes, 10% for 12 minutes, and finally 0% for the last 12 minutes.  Speed was 
started at 0.5 km/hr and adjusted until 3.0km/hr as tolerated.  The BWSTT 
intervention improved UPDRS III by 18% (18.2 to 15.0, p<.001), gait speed became 
quicker (10.0sec/10m to 8.3sec/10m, p<.05), and less steps were needed over a 10 
metre walk (22.3 to 19.6, p<.01).  Variability of gait was unable to be measured due 
to gait characteristics being obtained by stopwatch and counting.  Although this study 
highlights the benefits of BWSTT, no comparison group of regular treadmill training 
was available. 
To further examine the efficacy of BWSTT within PD, Toole [19] had three 
separate conditions consisting of a group that was not under any BWS, a group with 
25% of their bodyweight unloaded, and lastly a group that trained with an additional 
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5% of their body weight.  This study was conducted to determine if BWS has an 
influence on therapeutic effect of TT within PD. Participants trained 3 times a week 
for 6 weeks, with each session lasting 20 minutes.  Intensity was relatively low, with 
patients in all groups training at 60% of their AAMHR.  Despite what condition 
patients were in, improvements were observed in gait, UPDRS III, and balance 
measures.   Reductions in UPDRS III scores were minimal (as only a 9% 
improvement was noted). This study concluded that the amount of body weight 
support during treadmill training does not affect symptom improvement.  
To determine the effect of high velocity treadmill walking, Herman employed 
a progressive and speed dependent TT program under the premise that bradykinesia 
and hypokinetic gait can be remedied by practicing to walk at a fast velocity.  The 
program was 6 weeks long, and sessions ran four times a week. Patients were 
harnessed in order to prevent falling, but bodyweight was not unloaded.  Treadmill 
speed was dependent on comfortable overground walking speed, which was assessed 
at the start of every week.  During the first 2 weeks, patients trained at speeds at or 
below overground walking speed.  By week 3, PD participants walked at speeds 
ranging from 5-10% greater than their overground walking speed.  A large reduction 
in UPDRS III was noted  (scores improved by 25% (29 to 22, p<.05)).  Measures of 
gait also improved, as self-paced gait became faster (1.11m/s to 1.26m/s, p<.05) after 
TT, most likely due to greater stride length (1.17m to 1.25m, p<.05).  This study was 
based upon progressively increasing walking speed and provided the actual gait 
velocity in which participants were trained at.  However, it is important to consider 
that the study lacked a control group, and was an open label design.  
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The immediate (Pohl et al., 2003) and long-term (Cakit, Saracoglu, Hakan & 
Erdem, 2007) effects of fast paced treadmill programs have also been studied in the 
PD population. Although the previously mentioned Herman study was also based 
upon progressive speed dependent training, percentages relative to comfortable pace 
were used. The following studies differ because the speed was based upon 
percentages of maximal overground walking speed, rather than comfortable walking 
speed.   After one bout of maximal speed dependent treadmill training, increases were 
reported in self-paced gait velocity, alongside a reduction in percentage of gait spent 
in double support. To investigate the long term effects of maximal speed training, an 
8 week, 16 session intense speed dependent treadmill training demonstrated an 
increase in maximal tolerated walking speed from 1.9km/h (+/-0.75km/h) to 2.6km/h 
(+/-0.77km/h) p<.001 (Cakit et al., 2007).  Unfortunately, UPDRS III was only 
measured at baseline, so the effect of maximal speed training on motor symptom 
severity remains unknown.  
Despite there being several previous TT interventions published for PD, 
several fundamental questions remain. It appears that nearly every sort of treadmill 
training despite speed, intensity or use of BWSTT has the ability to improve gait. 
However, only UPDRS III improvements and changes in cortical excitability were 
reported in high intensity protocols (Herman, 2007; Fisher, 2008).    TT interventions 
that alter cadence but match intensity (% of MHR) between training groups are 
needed to determine if the rate of exercise has an interaction with the intensity in 
regards to providing therapeutic benefit for motor symptoms of the PD. 
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ii. Forced Exercise  
Ridgel, Vitek & Alberts define forced exercise (FE) as exercise that is 
augmented mechanically to assist the participant in achieving and maintaining an 
exercise rate greater than their preferred rate of exercise.  The group utilized a 
stationary tandem bicycle setup where a trainer would pedal at the front of the cycle, 
effectively controlling the cadence of the rear cranks. By forcing the participant on 
the back of the cycle to maintain the cadence set by the trainer, the participant would 
be able to achieve and maintain a rate of exercise (in regards to cadence) greater than 
they could on their own while providing the same amount of effort.  This group was 
the first to adapt an FE paradigm that originally showed promise in rodent and animal 
models of PD (Lau, 2011; Tillerson, 2003). Their FE intervention resulted in a within 
group 35% decrease in total UPDRS-III score, in contrast to a control cycling group 
which saw no change, despite exercising at a matched duration, frequency and 
intensity (% of MHR).  The only identified difference between the successful FE 
group and the control condition was a difference in pedaling cadence.  Improvements 
in the FE group were also seen in upper limb outcome measures unrelated to the 
training protocol, leading researchers to conclude that the exercise may have caused 
global improvements in BG functioning.   A separate study by the same group 
showed that even a single bout of FE was capable of reducing bradykinesia and 
tremor (Ridgel, Peacock, Fickes & Kim, 2012).  These results demonstrated that not 
all exercise that is matched by aerobic intensity is equal in its therapeutic effect.  
Since pedaling cadence was the only reported difference between groups, the authors 
proposed that faster sampling rates of afferent somatosensory information 
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experienced by FE group could be responsible for the improvement in BG 
functioning. 
iii. Body awareness/other - Is somatosensory training the missing link? 
The contributions of somatosensory feedback during exercise are highlighted 
in the next few exercise programs, which are neither aerobic, intense, or speed based.  
Improvements in UPDRS-III scores have been reported in interventions such as Tai 
Chi (Yang, Li, Gong & Zhu, 2014), PD SAFEx (Sage & Almeida, 2009, Sage & 
Almeida, 2010), and Qi Gong (Schmitz-Hubsch, Pyfer, Kielwen, Fimmers, & 
Klockgether, 2006).  These interventions focus on body awareness, and force 
Parkinson’s patients to rely heavily on somatosensory information to maintain 
balance and stability.  The mechanisms responsible for the improvement of symptoms 
are still unknown for body awareness based exercises, however, an improvement in 
the processing of somatosensory information may in part be responsible for the 
improvements in motor symptoms (Sage, 2008; Sage, 2009).  Work that has 
examined sensory feedback during movement in PD have supported that the 
processing of somatosensory information is disrupted in Parkinson’s disease 
(Abbruzzese & Berardelli, 2003; Zia et al. 2000; Konczak et al., 2007).  Additionally, 
other research has proposed that the deficits in sensory processing may actually 
contribute to the motor symptoms of PD (Jacobs & Horak, 2006; Abbruzzese, 2004).  
Due to the possibility that poor processing of somatosensory information within the 
BG contributes to the motor symptoms of the disease, an improvement in integration 
of somatosensory information could be a causal factor in regards to improvements in 
motor symptoms. 
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MUSCLE SPINDLE AND GOLGI TENDON ORGAN FUNCTION/PHYSIOLOGY 
 The term somatosensory feedback refers to the afferent sensory message 
provided by proprioceptors in the body that allow for the detection of movement, 
muscle tension and physical location in space. The two primary proprioceptors 
discussed in this thesis are muscle spindles and Golgi tendon organs (GTO).  Muscle 
spindles are stretch-sensitive mechanoreceptors that are found in virtually all 
mammalian skeletal muscle.  Their function is to provide the central nervous system 
with information about length and changes in length of a muscle (Proske, 1997). In 
regards to the afferent signal that is created sent to the CNS, as the muscle is 
lengthened, the spindle increases its frequency of discharge in proportion to the 
length of the sarcomere (Burke, Hagbarth & Löfstedt, 1978).  
 The other proprioceptor discussed in this thesis is the GTO, which provides 
the CNS with information regarding the tension that a muscle fiber is subject to.  
GTO’s are very sensitive to changes in tension, as the activation threshold for this 
particular proprioceptor is very low (Jami, 1992).  As the GTO is put under more 
strain, the output of action potentials becomes more frequent, providing the CNS 
information that the muscle is under greater load.  Furthermore, as more motor units 
are recruited to perform a task that requires more tension, a greater quantity of GTOs 
will begin to discharge (Horcholle-Bossavit, Jami, Petit, Vejsada & Zytnicki, 1988). 
 In the middle section of this thesis, the terms RATE and MAGNITUDE are 
used as descriptors for somatosensory feedback that the exercise programs are 
intended to generate.  During regular walking, the CNS is receiving information from 
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both the GTO’s and muscle spindles as muscles extend and contract while being 
subjected to varying tension.  The RATE group, which consists of walking at a fast 
cadence causes length sensitive muscle spindles to discharge more frequently, as a 
greater amount of gait cycles are occurring in a given period of time. This more 
frequent discharge from length sensitive muscle spindles is the basis for the RATE 
title, as the CNS receives this stretch/shortening message more frequently. The 
treadmill program that was deemed “MAGNITUDE” was intended to generate a 
greater discharge from tension sensitive GTO’s. This was accomplished by having 
participants wear ankle weights during walking in an effort to elicit greater tension at 
the flexors of the hip and extensors of the knee during walking.  Assuming that the 
ankle weights lead to greater muscle tension during gait, the greater amount of 
discharge from GTO’s particularly during toe off and swing would provide a signal to 
the CNS that is greater in magnitude.  Thus, compared to regular treadmill walking 
the feedback from GTO’s would be of greater magnitude due to the use of the ankle 
weights.  
THERAPEUTIC CONTRIBUTIONS OF SOMATOSENSORY FEEDBACK  
 Recently, the contributions of afferent, somatosensory feedback from muscle 
spindles, golgi tendon organs and joint receptors has been proposed to be a 
mechanism responsible for the therapeutic effects of exercise for those with PD 
(Alberts et al., 2011; Ridgel et al., 2012).  This hypothesis is supported by research 
that shows that afferent feedback has the ability to alter corticomotor excitability 
(Coxon, Stinear & Byblow, 2005; Cheng J, Brooke JD, Misiaszek JE, Staines WR, 
1995).  Furthermore, work reporting therapeutic effects from whole body vibration 
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therapy in PD has also proposed somatosensory feedback as the mechanism 
responsible for motor symptom improvement (King, Almeida & Ahonen, 2009; Haas 
CT, Turbanski K, Kessler K & Schmidtbleicher, 2006).  The incoming somatosensory 
feedback may reset or perturb the abnormally slow neural rhythms that occur in the 
Parkinsonian brain (King, Almeida & Ahonen, 2009).  Exercise based evidence for 
this hypothesis stems from forced exercise studies where training variables such as 
heart rate and output (watts) are matched between groups, while cadence differs 
(Alberts et al., 2011).  Only groups that trained at fast cadences received therapeutic 
benefits, leading the authors to conclude that a higher rate of sampling from 
somatosensory afferents was the only difference between groups.   
 Although the argument that high rates of sampling of somatosensory 
information is what leads to therapeutic benefits of high cadence exercise, it is 
important to consider that the previously mentioned body awareness and resistance 
based exercises that have also been shown to be capable of improving the motor 
symptoms rely on somatosensory information, but in a different manner.  Body 
awareness based exercises are not quick or high rate in nature, but rather are slow and 
generate high magnitudes of somatosensory feedback.  Therefore, it is possible that 
exercise interventions that generate greater magnitudes of somatosensory feedback by 
increasing the discharge frequency from GTO’s may be just as effective as those that 
are based upon generating high rates of somatosensory feedback in regards to their 
therapeutic qualities.  
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THESIS OBJECTIVES 
 The objective of this thesis is to explore the therapeutic capability of three 
different treadmill exercise programs. The first treadmill condition is deemed the 
RATE group, and will have participants walk while maintaining a fast cadence.  The 
next treadmill condition is the MAGNITUDE group, where participants will walk 
with ankle weights. Lastly, a CONTROL treadmill exercise program consisting of 
participants walking at their voluntary speed will serve as an active comparator.  The 
variations in types of treadmill training programs were carefully manipulated with  
the intention to vary the type of somatosensory feedback they generate. This work 
will hopefully provide insight to the therapeutic contributions of somatosensory 
feedback during exercise, and allow for a further understanding of which specific 
traits of exercise for those with PD are beneficial.   
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Chapter 2 
The therapeutic contributions of somatosensory feedback during exercise in 
Parkinsons disease; a randomized, controlled trial. 
ABSTRACT 
Background: Somatosensory feedback generated from exercise has been 
hypothesized to be in part responsible for the therapeutic effects of forced-exercise in 
Parkinson’s disease (PD).  Objective: To explore the influence of different forms of 
somatosensory feedback and their contribution to motor symptom improvement from 
exercise in PD. Methods: 48 patients with idiopathic PD were randomized into 3 
different treadmill exercise programs (RATE, MAGNITUDE, CONTROL). 
Participants were evaluated before and after the program using the motor section of 
the Unified Parkinson’s Disease Rating Scale (UPDRS-III) and objective measures of 
both gait and postural control. All programs lasted 6 weeks with sessions occurring 3 
times a week. Results: Baseline measurements revealed no statistical differences 
between groups. 9 participants withdrew. Despite all groups exercising at a matched 
intensity, frequency and duration, only the RATE group significantly reduced their 
UPDRS-III (23.35  8.13 to 18.85  7.17, P<.01). Furthermore, this group improved 
on an upper limb subsection of the UPDRS-III  (12.00  5.39 to 9.15  4.14, P<.01). 
Conclusion: A high sampling rate of somatosensory feedback appears to be a trait of 
exercise that contributes to its therapeutic effect in PD. Those exercising for 
therapeutic benefit with PD should consider including activity that is rapid and 
repetitive in nature.   
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INTRODUCTION 
 
Parkinson’s Disease (PD) is a progressive movement disorder with motor 
symptoms such as tremor, bradykinesia, rigidity, postural instability, and gait 
impairment (Guttman, Kish & Furukawa, 2003; Rocchi, Chiari & Horak, 2002). 
Dopamine replacement therapy (DRT) is the most common and accessible treatment 
for motor symptom management (Rascol, Payoux, Ory, Ferreira, Brefel-Courbon & 
Monastruc, 2003; Parkinson Study Group, 2000). Although DRT ameliorates cardinal 
motor symptoms, its use is commonly accompanied by bothersome physical and 
mental side effects (Fahn, 1996; Fahn et al., 2004). Furthermore, postural instability 
and gait dysfunction respond minimally to DRT, leaving two symptoms associated 
with the high morbidity in PD minimally treated (Sethi, 2008; Hely, Morris, Reid & 
Trafficante, 2005). The compromising and incomprehensive aspects of DRT stress 
the importance of developing alternative and complimentary methods of motor 
symptom management in PD. 
Exploring the efficacy of exercise and physical activity to improve the motor 
symptoms of PD has been a popular area of research in recent years. (Ridgel, 
Peacock, Fickes & Kim, 2012; Herman, Giladi, Gruendlinger & Hausdorff, 2008; 
Alberts, Linder, Penko, Lowe & Phillips, 2011; Sage & Almeida, 2009; Sage & 
Almeida, 2010; Yang et al., 2014; Li, Harmer & Fitzgerald, 2012; Corcos et al., 2013, 
Miyai et al., 2000). Aerobic exercise on treadmill, bicycle, resistance training, and 
body awareness exercises such as Tai Chi, and Sensory Attention Focused Exercise 
(PD SAFEx) have been shown to be successful in providing motor symptom relief, 
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measured by the motor subscale of the Unified Parkinson’s Disease Rating Scale 
(UPDRS-III). However, despite the amount of research that has been conducted on 
exercise and PD, which specific qualities and traits of exercise responsible for 
evoking a therapeutic response remain largely unknown.  
Recently, somatosensory feedback generated during exercise from muscle 
spindles, golgi tendon organs and joint receptors has been proposed to contribute to 
the therapeutic of exercise on the motor symptoms of PD (Ridgel et al., 2012; Alberts 
et al., 2011) This is concurrent with research demonstrating that varying 
somatosensory afferent feedback alters corticomotor excitability (Coxon, Stinear & 
Byblow, 2005; Cheng, Brooke, Misiaszek & Staines, 1995). Furthermore, work 
reporting therapeutic effects from whole body vibration therapy in PD has also 
proposed somatosensory feedback as the mechanism responsible for motor symptom 
improvement (King, Almeida & Ahonen, 2009; Turbanski, Haas, Schmidtbleicher, 
Friedrich & Duisberg, 2005).  The incoming somatosensory message relays through 
the thalamus, and may reset or perturb abnormally slow and asynchronous neural 
rhythms that occur in the Parkinsonian brain (Levy, Ashby, Hutchison, Lang, Lozano 
& Dostrovsky, 2002; Brown, Olivviero, Mazzone, Insola, Tonali & Di Lazzaro, 2002; 
Marsden, Limousin-Dowsey, Ashby, Pollak).  Applied exercise based evidence for 
this hypothesis stems from forced exercise (FE) studies where participants are 
assisted to achieve an exercise intensity that they would not be capable of maintaining 
on their own.  In FE, variables such as heart rate and output (watts) are matched 
between groups, while only cadence differs.  Only the rapid cadence FE group 
received therapeutic benefits leading to the possibility that a high rate of 
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somatosensory sampling generated from FE was partly responsible for motor 
symptom improvement reported (Alberts et al., 2011).   
Although it is possible that a high rate of afferent sampling is a contributing 
factor towards the therapeutic benefits of exercise, it is important to consider that 
rapid, high cadence exercise is not the only type of exercise that has reported 
UPDRS-III improvements.  Previously mentioned body awareness and strength 
training exercises are not quick or high rate in nature, but rather are slow and 
methodical.  In regards to afferent feedback, these types of exercise would generate 
high magnitudes rather than high rates of somatosensory feedback.  Therefore, if 
somatosensory feedback generated from exercise is a contributing factor for 
therapeutic benefit, it is possible that generating a high magnitude of feedback may 
also be beneficial. This raises the need for a randomized, controlled study which 
matches intensity, type, and duration of exercise while manipulating the 
characteristics of somatosensory feedback that the participant receives.  One way of 
manipulating somatosensory feedback while keeping other training variables constant 
is by using body weight supported treadmill training (BWSTT), as more body weight 
can be removed to facilitate high rate exercise that would otherwise be difficult or 
impossible for a Parkinson’s patient to maintain.  
The aim of the current study was to explore the therapeutic contribution of 
various forms of somatosensory feedback generated during exercise. It is 
hypothesized that exercise that generates a high RATE of somatosensory feedback 
will improve motor symptoms of the disease. Furthermore, the therapeutic effect of 
somatosensory feedback that is greater in MAGNITUDE during exercise was 
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explored. The objective is to provide those responsible for exercise prescription in PD 
an indication of how somatosensory feedback may contribute to the therapeutic 
improvements reported from certain forms of exercise in PD.  
METHOD 
Participants 
Participants were recruited from the Sun Life Financial Movement Disorders 
Research and Rehabilitation Centre (MDRC) at Wilfrid Laurier University in rolling 
fashion from October 2013 to June 2014. Inclusion criterion included a diagnosis of 
idiopathic PD, the ability to walk without the aid of an assistive device for 10 metres, 
no history of cerebral or myocardial infarction, and no musculoskeletal issues in the 
lower limbs or back that would affect ability to walk for sustained periods of time. 
All participants provided PARmed-X forms that were signed by a physician to ensure 
that they were fit for exercise. Participants were removed from the analysis if they 
missed more than 2 sessions or changed medication at any time during the 
intervention. Informed written consent was provided prior to any participation or 
assessment.  The study was approved by the Wilfrid Laurier University ethics board 
and was registered with clinicaltrials.gov ID #NCT01987557. 
Sample Size Calculation 
A sample size of 13 was required to detect a 3.5 point change in the UPDRS-
III with an assumption of 80% power.  This chosen value was conservative estimate 
based off of a minimally clinical important change (MCIC) which has been reported 
to be between 2.4 and 2.7 points (Shulman et al., 2010)  
Randomization 
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Participants were randomized into 1 of 3 training groups by a random number 
generator after initial assessments were completed to ensure that groups would be 
comparable by UPDRS-III (Figure 1). Randomization was done by a researcher who 
was not responsible for any assessments that were subjective in nature.   
Outcome Measures 
All tests were conducted within one week of the start of the intervention (Pre), 
and again during the week following the cessation of the intervention (Post).  All 
assessments were done in the “On” state of Parkinsonian medication. 
i. Unified Parkinson’s Disease Rating Scale (motor section) 
The primary outcome measure was the motor section of the Unified 
Parkinson’s Disease Rating Scale (UPDRS-III). An upper limb subscore (UPDRS-III 
UL) was generated using items 20-25 of the UPDRS-III.  A posture and gait subscore 
(UPDRS-III PG) was generated with items 27-31.  The UPDRS-III was conducted by 
a certified clinical assessor who was blinded to group assignment.  
ii. Spatiotemporal Aspects of Gait 
Spatiotemporal aspects of gait were generated from a 7.9m GaitRITE 
walkway (CIR Systems Inc, Havertown, PA) during self-selected, then maximal 
overground walking speeds.   The mean from 5 trials for each walking speed were 
used for analysis.   
iii. Postural Control 
 24 
Postural control was assessed on a Balance SD system (Biodex, Shirley, NY) 
using the Postural Stability Test (PST) and modified Clinical Test of Sensory 
Integration on Balance (m-CTSIB) modes. The postural stability mode assessed how 
well a participant could maintain their centre of balance during quiet stance.  This test 
was repeated 3 times for 20 seconds each on platform stability level 8, which has 
been validated in previous research (Arnold & Schmitz, 1998). The m-CTSIB 
assessed the ability to integrate various forms of sensory feedback which has been 
shown to be deficient in PD (Rinalduzzi et al., 2015). The m-CTSIB included 4 
conditions that were each tested once for 30 seconds. Baseline (eyes open, firm 
surface), vestibular/somatosensory interaction (eyes closed, firm surface), 
somatosensory/visual interaction (eyes open, dynamic surface), and 
somatosensory/vestibular interaction (eyes closed, dynamic surface). All values for 
postural control measures represent deviations from the centre of the platform.  
Training Statistics 
In addition to outcome measures, training data provided by the BIODEX Gait 
trainer 3.0 were recorded after each training session.  Training metrics consisted of 
heart rate, treadmill speed, stride length, and cadence.  Cadence was measured in gait 
cycles per minute and was derived from the total amount of steps taken during the 25 
minute training session.  Cadence (gait cycles per minute)=[(total steps/2)/25]. Heart 
rate readings from the handles of the Biodex gait trainer 3.0 treadmills were recorded 
every five minutes then averaged over the training session then converted to a 
percentage using the standard Karvonen formula (220-age) 
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Intervention 
The study consisted of 3 separate treadmill based exercise interventions that 
were deemed RATE, MAGNITUDE, and CONTROL.  All interventions trained 3 
times a week for 6 weeks for a total of 18 sessions.  All participants trained on the 
Biodex gait trainer 3.0 and wore the Biodex overhead harness to allow for the 
manipulations bodyweight and for safety to be ensured.  
Each session consisted of a 5 minute warm up where participants would walk 
at a self-selected speed, followed by a 25 minute session that varied depending on 
their group assignment, then an optional 2 minute cool down.  Participants were 
allowed to take breaks at anytime, however, break time was not included in the 25 
minute session. If participants reached a heart rate that was above 75% of their 
Karvonen age related maximum heart rate (AAMHR), they were given a rest, which 
involved either walking slowly or sitting down until their heart rate dropped to below 
70% of their Karvonen AAMHR. 
i. “RATE” 
 Participants in this group were instructed to walk with as fast of a cadence 
(gait cycles per minute) as possible during their training sessions.  Body weight was 
removed via the Biodex harness to facilitate high cadence walking. The amount of 
bodyweight removed was determined by the participants’ preference. The protocol 
was based off of a forced exercise (FE) regime that reported improvements in motor 
function in those that bicycled at a cadence of 85.8(sd=0.8) revolutions per minute 
(RPM) (Alberts et al, 2011).  In an effort to replicate the high cadence, participants 
were verbally reminded to keep the cadence of their gait as close to the mark of 
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approximately 85 gait cycles per minute. To facilitate this, most participants in this 
group used a greater amount of body weight support.  
ii.  “MAGNITUDE” 
 Participants wore ankle weights to increase the response from tension 
sensitive golgi tendon organs (GTO’s) during gait that was larger in magnitude. 
Participants were given the instruction to walk at their preferred pace. Men wore 3lb 
weights on each ankle and women wore 2 lb weights on each ankle.  For the first 3 
sessions, the amount on each ankle was one pound less to allow for participants to 
safely adjust to the ankle weights. 
iii. “CONTROL” 
 In the control condition, participants were still harnessed and the amount of 
bodyweight removed was determined by the participants’ preference.  Participants 
were told to train at their preferred walking pace.  Gait cues were given occasionally 
to promote proper gait.  
Statistical Analysis 
 The data were analyzed with Statistica version 7 (Statsoft).  For participant 
characteristics at pre and training variables, one way ANOVAs were used to examine 
group differences.  Main and secondary outcome measure differences from pre to 
post were analyzed with a repeated measures 3x2 (group by time) ANOVA. Post hoc 
analyses were conducted using Fishers LSD. The significance level was set at .05.  
For certain outcome measures, a post hoc analysis was run despite the absence of a 
significant interaction between group and time.  The use of more liberal statistics in 
these scenarios is justified by these comparisons being planned and stated in the 
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hypothesis. Furthermore, the UPDRS-III changes reported were considered to be 
moderately clinically meaningful differences (Shulman, 2010). 
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Table 1: Protocol Summary 
 Condition 
 “Rate” “Magnitude” “Control” 
Description  Treadmill walking 
with the goal of 
maintaining as fast 
of a cadence as 
possible.  
 Treadmill walking 
with ankle weights 
 Regular treadmill 
walking 
Body Weight 
Support (BWS) 
 All participants trained at their preferred amount of body weight 
support.  
 Due to participants 
training at a high 
cadence, most 
participants 
trained with a 
considerable 
amount of BWS. 
 A varying amount of BWS was used for 
training sessions to adapt the exercise to 
the capabilities of the participant. 
Cadence  All participants 
were instructed to 
walk with a step 
rate that was fast as 
possible and were 
given verbal cues if 
cadence became 
too slow.  
 No cues for cadence were given to 
participants during training sessions. 
Intensity  Intensity was based on participants’ % of age adjusted maximum 
heart rate using the *Karvonen formula (AAMHR).   
 When AAMHR reached became greater than 75% participants were 
given a rest until heart rate dropped to <70% AAMHR. 
*Karvonen formula for AAMHR=(220-age) 
 
 
 
 
 
 
 
 
 
 
 
 29 
 
Figure 1: Randomization flow chart 
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RESULTS 
 
Participants 
No significant differences in age, disease severity (UPDRS-III), or walking 
velocity between groups at PRE were identified (Table 2). 
Training Characteristics 
Training intensity, which was based on a percentage of the Karvonen age 
adjusted maximum heart rate (AAMHR) did not significantly differ between groups 
(p=0.18) for total training sessions. Participants in the RATE condition trained at a 
both faster velocity (p<.01), higher cadence (p<.001), and walked further compared to 
those in other conditions (p=0.39). Stride length was similar between conditions 
during training (Table 3). 
Adverse Events 
 No major adverse events occurred during the study.  1 participant withdrew 
due to hamstring pain, and another withdrew as a result of minor back pain (Figure 
1). 
Primary Outcome Measure 
UPDRS-III 
A main effect of time for all groups showed improvement on UPDRS-III 
scores (F(1,36)=9.93, p<.01), however, only participants in the RATE condition 
improved significantly (P<.01).  A significant main effect of time was reported across 
groups in an upper limb subscale (UPDRS-III UL) (F(1,36)=9.45, p<.01), again, only 
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the RATE condition improved significantly in the UPDRS-III UL (p<.01). No 
significant differences were detected in the posture and gait subscale (p>.05) (Table 
4). An interaction between group and time was not statistically significant for total 
UPDRS III F(2, 36)=1.0466, p=0.36, UPDRS III UL F(2,36)=2.39, p=0.11, and 
UPDRS-III PG F(2,36)=1.26, p=0.30. A post hoc was completed on the UPDRS-III 
and its subscales because a 4.5 point change in the RATE group is considered to be a 
moderately clinically meaningful change (Shulman, 2010).  Although statistical 
significance was not reached in the interaction, the clinical importance of this change 
merited the use of a post hoc test to examine this planned comparison.  
Secondary Outcome Measures 
Spatiotemporal Aspects of Gait 
Self-paced gait 
i. Velocity 
 A main effect of time was found for velocity (F(1,36)=9.75, p<.01).  Fisher’s 
LSD at post-hoc revealed that only the RATE (P<.01) and CONTROL (P<.05) 
conditions improved significantly in self paced walking velocity (Table 5).  A group 
by time interaction was not significant F(2,36)=2.38, p 0.11.  
ii. Stride Length 
A main effect of time was reported for stride length (F(1,36)=11.83, p<.01). 
Fisher’s LSD post-hoc showed that the RATE and CONTROL conditions improved 
significantly (P<.05) (Table 5). A group by time interaction was not significant 
F(2,36)=0.53, p=0.59.  
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iii. Cadence 
 A main effect of group was detected for cadence (F(2,36)=3.65, P<.05).  The 
MAGNITUDE group walked with a significantly lower cadence compared to the 
RATE and CONTROL groups (Table 5). A group by time interaction was not 
significant F(2,36)=3.066, p=0.06. 
Fast-paced gait 
i. Velocity 
A main effect of time on velocity was detected (F(1,36)=22.56, p<.001). Post-
hoc showed that the RATE (P<.01), MAGNITUDE (P<.05) and CONTROL (P<.01) 
groups increased fast paced walking velocity (Table 6). A group by time interaction 
was not significant F(2,36)=0.43, p=0.66 
ii. Stride Length 
A main effect of time was reported for stride length (F(1,36)=16.21, p<.001). 
Fisher’s LSD post-hoc showed that the RATE and MAGNITUDE groups increased 
their stride length during fast paced walking (P<.05) (Table 6). A group by time 
interaction was not significant F(2,36)=0.41, p=0.67 
iii. Cadence 
 No significant differences were detected for cadence during fast paced 
walking.  
Balance and Postural Control  
Modified Clinical test of Sensory Integration on Balance (m-CTSIB) 
No significant differences were observed in the m-CTSIB (Table 7). 
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Postural Stability Testing (PST)  
No significant differences reported in total, anteroposterior, or mediolateral PST 
scores (Table 7). 
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Table 2: Participant characteristics at baseline 
  Rate Magnitude Control P value 
N 13 13 13 n/a 
Age 63.77 (7.01) 70.46 (9.52) 
66.31 
(9.07) 
p=.16 
UPDRS III "PRE" 23.00 (8.51) 22.96 (6.93) 
22.46 
(8.64) 
p=.98 
Gender m=10, f=3 m=12, f=1 m=12, f=1 n/a 
Self paced walking 
velocity (cm/s) 
116.19 (24.09) 
122.54 
(8.58) 
116.21 
(30.24) 
p=.71 
 
UPDRS-III, Unified Parkinson’s Disease Rating Scale (motor subsection). One way 
ANOVA used to determine differences between groups at PRE.  Disease severity 
(UPDRS-III) and age were comparable at PRE.  Bracketed numbers represent 
standard deviations. 
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Table 3: Training Statistics 
  Rate Magnitude Control Sig 
Intensity (% of AAMHR) 67% (3.83%) 68%  (3.79%) 64% (5.60%) p=.18 
Velocity (km/h) **5.63 (0.60) 4.60  (0.97) 4.63 (1.24) p=.01 
Cadence (gait cycles per minute) **80.21 (1.85) 59.68 (4.12) 59.85 (3.41) p<.001 
Total distance (m) *2773.31 (310.22) 
2318.62 
(451.22) 
2329.31 
(661.29) 
p=.039 
Stride Length (cm) 151.69 (17.07) 160.00 (21.88) 148.15 (29.21) p=0.42 
 
AAMHR, Karvonen based age adjusted maximum heart rate (220-age) 
*P<.05 difference one way ANOVA between groups 
**P<.01 difference one way ANOVA between groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4: UPDRS-III  
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 Rate Magnitude Control 
UPDRS-III    
    Pre 23.35 (8.13) 22.96 (6.93) 22.46 (8.64) 
    Post **18.81 (7.17) 20.69 (8.39) 20.92 (6.14) 
UPDRS-III PG    
    Pre 2.92 (2.23) 2.88 (1.40) 4.04 (3.48) 
    Post 2.42 (1.89) 3.03 (1.81) 3.24 (3.04) 
UPDRS-III UL    
    Pre 12.00 (5.39) 11.15 (4.14) 10.8 (5.02) 
    Post **9.15 (4.14) 10.15 (5.90) 10.27 (4.62) 
 
UPDRS=Unified Parkinson’s disease rating scale, PG=Posture and gait subscore 
(items 27-31 of UPDRS), UL=Upper limb subscore (items 20-25 of UPDRS). 
Bracketed numbers represent standard deviations. 
**P<.01 using Fisher’s LSD post hoc within groups 
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Table 5: Spatiotemporal aspects of self-paced gait 
 Rate Magnitude Control 
Velocity (cm/s)    
    Pre 117.07 (24.09) 122.64 (8.58) 116.2 (30.24) 
    Post **129.38 (21.30) 125.56 (20.51) *124.5 (32.33) 
Stride Length 
(cm) 
   
    Pre 125.46 (26.29) 136.6 (11.87) 122.48 (28.52) 
    Post *133.62 (27.04) 140.32 (17.48) *128.77 (29.53) 
Cadence (steps 
per minute) 
   
    Pre 111.59 (7.36) 107.85 (7.50) 112.97 (9.86) 
    Post 116.82 (8.88) 105.28 (10.45) 115.44 (10.90) 
Bracketed numbers represent standard deviations.  
              *P<.05 using Fisher’s LSD post hoc within groups 
            **P<.01 using Fisher’s LSD post hoc within groups 
 
 
 
 
 
 
 
 
 
 
 
Table 6: Spatiotemporal aspects of fast paced gait 
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Outcome Measure Rate Magnitude Control 
Velocity (cm/s)    
    Pre 156.54 (37.33) 164.83 (22.32) 155.92 (43.98) 
    Post **169.12 (26.95) *176.87 (20.83) *165.47 (48.02) 
Stride Length 
(cm) 
   
    Pre 143.27 (31.00) 158.69 (37.18) 143.54 (37.18) 
    Post *150.31 (28.13) **166.57 (17.66) 148.02 (35.87) 
Cadence (steps 
per minute) 
   
    Pre 130.06 (10.17) 127.34 (13.90) 130.72 (11.42) 
    Post 135.75 (12.11) 125.78 (13.06) 132.67 (17.37) 
    Bracketed Numbers represent standard deviations.  
               * P<.05 with Fisher’s LSD post hoc within groups 
               **P<.01 with Fisher’s LSD post hoc within groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7: Measures of balance and postural control 
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   Rate Magnitude Control 
m
-C
T
S
IB
 
Full Sensory 
Availability 
   
   Pre 0.76 (0.22) 0.78 (0.21) 0.85 (0.31) 
   Post 0.80 (0.29) 0.82 (0.29) 0.76 (0.25) 
Somatosensory 
Dominant    
   Pre 1.26 (0.46) 1.34 (0.33) 1.73 (1.11) 
   Post 1.28 (0.50) 1.56 (0.63) 1.62 (0.62) 
Visual Dominant    
   Pre 1.15 (0.30) 1.42 (0.49) 1.32 (0.45) 
   Post 1.21 (0.40) 1.43 (0.63) 1.24 (0.48) 
Vestibular Dominant    
   Pre 2.9 (0.77) 3.3 (1.25) 3.24 (1.26) 
   Post 2.9 (1.00) 3.15 (1.11) 3.43 (1.85) 
P
o
st
u
ra
l 
S
ta
b
il
it
y
 
T
es
t 
(P
S
T
) 
Overall    
   Pre 1.38 (0.29) 1.68 (0.52) 1.85 (0.51) 
   Post 1.54 (0.50) 1.78 (0.61) 1.71 (0.77) 
Anteroposterior    
   Pre 0.98 (0.37) 1.25 (0.49) 1.26 (0.51) 
   Post 0.97 (0.39) 1.25 (0.56) 1.15 (0.58) 
Mediolateral    
   Pre 0.78 (0.24) 0.88 (0.25) 1.07 (0.34) 
   Post 0.96 (0.37) 1.01 (0.32) 1.03 (0.47) 
 
Full sensory availability=eyes open on firm surface, somatosensory dominant=eyes 
closed on firm surface, visual dominant=eyes open on foam surface, vestibular 
dominant=eyes closed on foam surface. Values are representative of deviations from 
the centre of the platform. Bracketed numbers represent standard deviations.  m-
CTSIB, modified clinical test of sensory integration on balance.  
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Figure 2: UPDRS III change over time.  A main effect of time was reported for all 
participants. At post hoc, only the RATE group showed significant improvement 
*P<.05 Fisher’s LSD Post hoc within groups 
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The aim of the current study was to evaluate the influence of different types of 
afferent feedback elicited from exercise have on the motor symptoms of PD. Results 
showed that a high sampling rate of afferent feedback was the most therapeutic, as 
only the RATE group which trained at a high cadence significantly improved their 
UPDRS-III symptom scores at post. Furthermore, participants in this condition 
improved on an upper limb subscore of the UPDRS-III.  Since treadmill training 
involves little use of the upper limbs, the improvement in upper limb functioning 
cannot be explained by practice or motor learning theories, but rather may be 
indicative of an improvement in BG functioning.  Lastly, considering that intensity, 
type, frequency, and duration of training were matched between all training groups, 
the type of afferent feedback that exercise generates must be a key consideration for 
exercise prescription for those with PD, as this study demonstrated that a high rate of 
afferent feedback is most effective in regards to improving the motor symptoms of 
PD.  
The hypothesis that high rates of afferent somatosensory feedback from 
muscle spindles and golgi tendon organs (GTO’s) facilitates the motor symptom 
relief seen from exercise was initially proposed by Alberts et al.  Their high cadence 
protocol showed a 35% improvement in UPDRS-III scores compared to regular 
cadence exercise control group. The current study supports the Alberts et al. findings 
regarding the therapeutic effect of high cadence exercise, but showed a more modest 
20% improvement in UPDRS-III.  This is likely because the current study included 
participants that were much less severe and were assessed during the “on” state of 
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medication, potentially contributing to a ceiling effect. Also, the cadence was slightly 
slower in the current study (80.21 rpm in current, compared to 85.8 rpm in Alberts et 
al.). This eludes to the possibility that participants may not have trained with a fast 
enough cadence to achieve maximal benefits.  This was due to the exercise occurring 
on a treadmill in the current study, and it being more difficult to maintain a fast 
cadence while walking opposed to bicycling.   
Unfortunately, the mechanism explaining why a high rate of somatosensory 
feedback is therapeutic still remains unknown.  However, the high sampling rate of 
afferent information from muscle spindles and GTOs, which propagates up the dorsal 
column-medial lemniscus pathway into the thalamus may act as a pacemaker and 
perturb the abnormal oscillatory rhythms in the beta frequency between the BG and 
thalamus that have been reported to occur in PD (Brown et al., 2001; Marsden et al., 
2001). After multiple sessions of high rate exercise, the abnormal spike in beta band 
frequencies reported during movement in PD may be attenuated, causing 
improvements in motor symptoms.  
 Alongside of changes in UPDRS-III scores, improvements were reported in 
spatiotemporal aspects of gait.  Due to the intervention being treadmill based, 
improvements in gait were expected across all groups as a result of motor learning.  
This is congruent with previously completed treadmill studies that have shown 
improvements in gait (Herman et al., 2007; Fisher et al., 2008; Miyai et al., 2000; 
Cakit, Saracoglu, Hakan & Erdem, 2007; Pohl, Rockstroh, Ruckriem, Mrass & 
Merholz, 2003). However, this study was the first treadmill training paradigm to 
compare varying forms of somatosensory feedback and their therapeutic effects on 
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gait. During self paced gait, improvements were observed in velocity and stride 
length, however, only for the RATE and CONTROL conditions (Table 4).  Although 
not significant, both stride length and velocity were considerably higher at “pre” for 
the MAGNITUDE group possibly explaining why this group did not improve after 
the intervention. During fast paced gait, significant improvements in velocity were 
observed in all conditions while only the RATE and MAGNITUDE groups increased 
their stride length (Table 5).  Typical Parkinsonian gait consists of a slow walking 
velocity caused by a shorter step length (Morris, Iansek, Matyas & Summers, 1996).  
Usually, a higher cadence is employed as a compensatory mechanism for a shorter 
stride length (Morris, Iansek Matyas & Summers, 1994). In the current study, changes 
in cadence were not significant for self paced or maximal gait speeds in any group, 
leading us to conclude that treadmill walking improves gait velocity by improving 
step length, which is the root cause of slow walking in PD. Improvements in gait in 
the current study are similar to previously completed treadmill programs that are 
acute (Pohl, 2003) and long term, ranging from moderate (Miyai, 2000) to intense 
(Herman, 2007; Fisher, 2008) aerobic intensity, the use of body weight support 
(Miyai, 2000), and speed dependent training (Cakit, 2007). A wide variety of 
treadmill programs including the current study have demonstrated that treadmill 
training is a safe and effective therapy for improving gait in PD.  
The precise mechanism explaining why treadmill training can improve gait is 
still unknown.  One inherent characteristic of a treadmill is that it moves at a constant 
speed, and has been demonstrated to promote more rhythmic and uniform gait 
(Frenkel-Toledo, Giladi & Peretz, 2005; Lim, Van Wegen, de Goede et al., 2005). 
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Thus, the somatosensory message from receptors in the legs and feet is more 
rhythmic and may promote neuroplastic changes in the CNS to areas responsible for 
pace and rhythm of gait at either spinal or supraspinal areas.  Interestingly, during fast 
paced walking, only conditions that received altered somatosensory feedback (RATE, 
MAGNITUDE) improved their step length.  The effectiveness of altered feedback 
during maximal paced walking may be due to the proprioceptive deficits reported in 
PD (Rickards & Cody, 1997; Khudados, Cody & O’Boyle, 1999). The altered 
somatosensory feedback generated from the ankle weights, or the faster sampling of 
somatosensory information from the high cadence RATE group, may improve how 
this information is being processed.  The improved proprioception may lead to a 
greater extensor load response in which the afferent feedback causes an increased 
output from the extensors in the lower leg (Dietz & Duysens, 2000). A greater 
extensor load response contributes to greater force at toe off, and thus, a greater step 
length and velocity (Dietz & Colombo, 1998). 
Due to treadmill training being based upon walking, it is difficult to determine 
if improvements are from a practice effect, or an improvement in BG functioning. If a 
practice effect were to explain the improvements in gait velocity, those in the RATE 
group would likely have relied on an increased cadence to improve gait velocity.  
However, this was not the case, as only stride length was increased significantly.  
Furthermore, since no improvements were detected in any measures of postural 
control, improvements in gait cannot be attributed to improvements in balance. Since 
all participants were harnessed during treadmill walking, it is likely that balance was 
not stressed during the intervention, and thus not improved.  
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Aside from manipulations in somatosensory feedback between groups, it is 
important to note that the RATE group also differed in the amount of steps they took, 
which was a requisite of maintaining a fast cadence and thus a high rate of 
somatosensory feedback. High cadence walking should be considered more 
volitionally controlled than self-paced walking because the participant must 
constantly attend to the maintenance of a fast cadence, which is an unnatural 
adaptation. This leads to an alternative explanation for motor symptom improvement 
in the RATE group explained by goal directed exercise.  In healthy individuals, motor 
performance relies on an interaction of volitional and automatic control centers 
(Mazzoni & Wexler, 2009). As PD progresses, the loss of dopaminergic projections 
to brain centers responsible for the automatic control of movement force PD patients 
to rely more heavily on volitional control centers (Redgrave, Rodriguez, Smith et al., 
2010). This reliance on volitional control for movements causes those with PD to 
carry larger cognitive loads to ensure successful motor control, which may lead to 
difficulties while performing more complex and intricate movements.  Therefore, 
goal directed exercise, which is the practice of certain activities that lead to improved 
performance, may be able to improve the cognitive aspect of motor output by making 
actions more learned and automatic (Petzinger, Fisher, McEwen et al., 2013). In the 
current study, the RATE group was the most goal directed of the conditions, due to 
participants having to maintain a high cadence during walking.  High cadence 
walking should be considered goal directed exercise because the maintenance of a 
high cadence is an unnatural movement, and requires constant volitional control.  
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Goal directed movement may lead to neuroplastic changes that revert motor outputs 
that were volitional movement back to more natural and automatic.  
IMPLICATIONS 
 The current study provides evidence that high rates of somatosensory 
sampling may be a key attribute of exercise in regards to improvements on motor 
symptoms of PD.  Those prescribing aerobic exercise to PD patients should consider 
incorporating exercise that is high rate in nature (fast cadence).  Future research 
examining the therapeutic contributions of varying forms of somatosensory feedback 
should include outcome measures that examine BG functioning directly either by 
transcranial magnetic stimulation or positron emission tomography.  The use of these 
objective measures will provide more in depth evidence of how altered 
somatosensory feedback may be improving BG functioning.  
LIMITATIONS 
Due to the intense nature of the exercise, only those with mild to moderate PD 
with minimal gait impairment are able to actually perform the exercise properly.  Due 
to time and equipment constraints, the sample was limited to 13 in each group.  A 
potential confounder in the study was that the amount BWS that each participant used 
over the course of the exercise sessions was not recorded. With varying amounts of 
BWS, more or less load is experienced by the participant during exercise. The 
varying amount of load during gait is a concern due to GTO activation (being 
sensitive to load) was a main manipulation in the study and is an uncontrolled for 
confounder. Additionally, the average heart rate data was generated using a 220-age 
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Karvonen formula.  An individually generated maximum heart rate for each 
participant during pre-testing would have been a more accurate method of 
determining average heart rate.  Lastly, the use of beta blocking medication that is 
common in an older population may have lead to heart rates readings that were not 
representative of the intensity of exercise that was being performed.  Issues with heart 
rate accuracy lead to the possibility that groups did not train at matched aerobic 
intensities, introducing a possible confounder explaining differences between groups.  
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Appendix A: Additional Outcome Measures 
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The purpose of this additional results section is to provide an objective 
measure of how upper limb motor performance was affected by the exercise 
interventions.  Since treadmill exercise can be considered mainly lower limb 
dominant, improvements in upper limb tasks unrelated to the intervention may be 
representative of overall basal ganglia improvement, as opposed to lower limb 
improvements that may be explained by practice or the principle of specificity.  
Although the UPDRS-III has a thorough section devoted to the upper limbs, the 
subjective nature of the assessment often draws criticism for its lack of sensitivity.  
To acknowledge this, two objective measures of upper limb function were tested at 
pre and post.   
The first objective measure of upper limb function was performance on a 
grooved pegboard, which has previously been shown to strongly correlate to overall 
UPDRS-III scores (Sage, Bryden, Roy & Almeida, 2012).  The other objective 
measure was the Kinesia Homeview tablet, which emulates the upper limb tasks of 
the UPDRS-III, but generates scores from an accelerometer on the hand that is being 
assessed.  This device has been previously validated and correlates strongly to clinical 
tremor (Giuffrida, Riley, Maddux, and Heldman, 2009), and bradykinesia scores 
(Heldman et al., 2011). Additionally, a Pearson’s correlation was used to examine 
how closely related the grooved pegboard and Kinesia Homeview scores were to the 
current gold standard of motor symptom severity within PD; the UPDRS-III.  All 
tests were conducted in the week prior to the start of the intervention (Pre), and again 
during the week following the cessation of the intervention (Post).  
Kinesia Homeview Assessment  
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 The Kinesia tablet receives data from an accelerometer placed on the pointer 
finger of each hand. The accelerometer provides a score from 0-4 on resting tremor, 
postural tremor, action tremor, rapid alternating movements, finger taps, and 
bradykinesia (hand grasps).  For the movement based tasks separate scores for 
velocity, rhythm, and amplitude score are provided.  All scores were summed for the 
respective hand (less affected, more affected).  More affected side was determined by 
the higher UPDRS-III score for the right or left hand. 
Grooved Pegboard 
A 25 peg Lafayette Instruments Grooved Pegboard was used. Participants 
were timed during both the place and removal phases for each hand for two trials 
each.  Participants were given a maximum time of 5 minutes.  The mean times for the 
two trials were averaged, and divided by the amount of successfully placed or 
removed pegs to provide a rate (seconds/peg).  
Statistical Analysis: 
 For the Homeview Kinesia and grooved pegboard, a 3X2 repeated measures 
ANOVA (groups x time) was used. For the correlation, a Pearson’s correlation was 
used.  Significance for all tests was set at 0.05.  
 
 
 
Results: 
Kinesia Homeview Assessment 
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1. Affected limb 
 An interaction between Group and Time (F(2,36)=3.69, p<.05) was found for 
Kinesia Homeview symptom score for the more affected limb.  Fisher’s LSD post 
hoc analysis showed that only the MAGNITUDE group improved significantly 
(Table 8). 
2. Non-Affected limb 
 No significant differences were observed in the non-affected limb in the 
Kinesia Homeview assessment (Table 8). 
Grooved Pegboard 
No significant differences were reported in the place or remove phase of the 
grooved pegboard task (Table 9).  
Correlational Results 
 Grooved pegboard “place” with more affected limb correlated to UPDRS-III 
(r=0.61,p<.05) and UPDRS-III UL (r=0.31, p<.05).  Place phase for less affected 
limb correlated only to total UPDRS-III score (r=0.50, p<.05) (Table 10).   
 Kinesia Homeview tablet with the more affected limb correlated strongly to 
overall UPDRS-III (r=0.73, p<.05) and UPDRS-III UL (r=0.65, p<.05). Kinesia 
Homeview score on the less affected limb also correlated significantly to UPDRS-III 
(r=0.55, p<.05) and UPDRS-III UL (r=0.44, p<.05) (Table 10).  
 
 
 
Table 8: Kinesia Homeview assessment 
  Rate Magnitude Control 
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More affected limb    
    Pre 13.60 (4.32) 14.91 (5.58) 15.58 (4.13) 
    Post 13.99 (5.03 *12.32 (5.62) 14.2 (3.31) 
Less affected limb    
    Pre 12.61 (3.90) 11.65 (4.77) 13.17 (3.22) 
    Post 12.06 (4.15) 11.34 (4.43) 12.07 (2.68) 
*P<.05 Fisher’s LSD post-hoc within groups.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 9: Grooved pegboard performance 
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  Rate Magnitude Control 
Less Affected "Place"    
    Pre 4.4 (1.69) 11.66 (25.54) 8.41 (14.36) 
    Post 3.97 (1.68) 17.45 (45.50) 5.52 (4.60) 
Less Affected "Remove"    
    Pre 0.86 (0.17) 0.97 (0.29) 1.13 (0.84) 
    Post 0.83 (0.19) 0.93 (0.32) 0.92 (0.23) 
More Affected "Place"    
    Pre 5.33 (4.18) 8.87 (9.53) 9.19 (14.26 
    Post 4.53 (1.33) 7.87 (9.16) 6.96 (6.31) 
More Affected "Remove"    
    Pre 0.88 (0.14) 1.06 (0.26) 1.18 (0.85) 
    Post 0.86 (0.14) 1.00 (0.30) 1.37 (1.56) 
All values are seconds per peg. Bracketed numbers represent standard deviations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 10: Correlations of upper limb measures to UPDRS-III 
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 Grooved Pegboard Kinesia Tablet 
 More Affected Place Less Affected Place More Affected Less Affected 
UPDRS III PRE *0.61 *0.5 *0.73 *0.55 
UPDRS III UL PRE *0.36 0.29 *0.65 *0.44 
Pearson product-moment correlation coefficients  
*p<.05 
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Chapter 3: 
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Grand Discussion 
The primary objective of this randomized, controlled trial was to understand 
the therapeutic contributions of somatosensory feedback manipulations during 
exercise programs for those with PD.  The purpose of examining this was to uncover 
potential mechanisms responsible for improvements in cardinal Parkinsonian motor 
symptoms from successful exercise interventions.  Having a greater understanding of 
the mechanism underlying therapeutic responses from exercise in PD is necessary, as 
it facilitates the development of more effective exercise prescription, and ideally 
establish exercise as a primary adjunct treatment for those with PD.   
The greatest challenge with understanding the mechanism(s) responsible for 
the therapeutic effects of exercise is that the modalities reported to be successful in 
improving the motor symptoms of the disease have been diverse in nature.  Thus, 
elucidating which components of exercise (type, frequency, duration, intensity) that 
possess therapeutic potential is difficult, as they range from aerobic interventions 
ranging from moderate (Miyai et al. 2000; Ridgel et al., 2009) to intense (Fisher et 
al., 2008; Herman, Giladi, Gruendlinger & Hausdorff, 2007), to strength training 
(Corcos et al., 2013), and body awareness based exercises (Li et al., 2012; Sage & 
Almeida, 2009; Sage & Almeida 2010).  One trait or component of exercise that 
appears to be common among all programs is that they are long term studies with 
repeated bouts of exercise.  Studies that have reported UPDRS-III improvement as a 
result of exercise have been longitudinal designs with a minimum duration of 4 weeks 
(Miyai, 2000), with most others ranging from 8-12 weeks (Herman, 2007; Sage, 
2009; Sage 2010; Ridgel, 2009). In regards to intensity, average heart rate data is not 
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provided in most studies, making it difficult to provide a threshold value that is 
necessary to maintain in order to obtain therapeutic benefits. This was addressed in 
the current study by ensuring all exercise groups trained at a matched age adjusted 
heart rate which ranged from 64% to 68% of a Karvonen based AAMHR.  A major 
finding in the current study was that improvements in UPDRS-III were different 
between groups despite all groups exercising at a matched AAMHR.  This led us to 
conclude that not all aerobic exercise has the same therapeutic potential, and that the 
somatosensory feedback generated from exercise is an important trait of exercise to 
consider.  
Due to the wide array of exercise modalities shown to be successful in 
improving the motor symptoms of PD, skeptics would argue that practically any and 
all exercise possesses therapeutic possibility for those with PD. To an extent, this 
argument is valid.   However, recent evidence stemming from more carefully 
designed studies employing blinded assessors, randomization, and the inclusion of 
suitable control groups have shown that only specific types of exercise have the 
ability to improve the motor symptoms of PD. In particular, Ridgel, Vitek & Alberts 
(2009) examined two bicycle based aerobic interventions that were matched in 
intensity (age adjusted maximum heart rate), duration, and frequency, while 
manipulating pedaling cadence between the groups.  Despite the aforementioned 
exercise traits being similar, only the group which pedaled at a fast cadence reported 
improved motor symptoms.  This was a critical finding because it was the first study 
to demonstrate that not all aerobic exercise possesses the same therapeutic potency. 
Although the sample was limited, the drastic improvements reported in the high 
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cadence group merited further investigation as to why high cadence exercise was 
therapeutic.   
In the current study, we attempted to conduct a randomized, controlled trial 
including three aerobic treadmill programs that were also comparable in regards to 
intensity, duration, and frequency. The main manipulation between groups was the 
somatosensory feedback that each of the different treadmill conditions elicited.  
Randomization was successful, as groups at pre-test were matched for symptom 
severity (UPDRS-III), age, and self-paced walking velocity. Furthermore, intensity of 
exercise (age adjusted maximum heart rate) was successfully matched between 
treadmill interventions.  This was a crucial component of the study to ensure that 
differing levels of aerobic intensity during exercise would not be a confounder 
between groups. In the current study, the RATE and MAGNITUDE conditions were 
considered to be the experimental conditions hypothesized to lead to motor symptom 
improvements (UPDRS-III), whereas the CONTROL group was meant to serve as the 
active comparator.  The inclusion of an active comparator control group was another 
key aspect of the study, as a non-exercising control group is often used in PD exercise 
based studies.  While still better than no control group, a non-exercising control may 
not adequately account for potential bias from the placebo of being involved in a 
study and receiving care, which can be particularly powerful in a Parkinsonian 
population (Lidstone, 2014).  
The primary finding was that the RATE condition was the only group to 
significantly improve their UPDRS-III scores. Furthermore, when all groups were 
collapsed together, UPDRS-III scores improved as a main effect of time. This led to 
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the conclusion that although all types of treadmill training in the current study should 
be considered successful, high cadence exercise (RATE group) was the most effective 
in reducing the motor symptoms of PD.  The success of the RATE condition supports 
another high cadence exercise program that was successful, albeit on treadmill rather 
than bicycle (Ridgel et al., 2009).  Ridgel also reported an improvement on an upper 
limb task unrelated to the exercise intervention, which was proposed to be an 
indicator of overall basal ganglia functioning.  Similarly, in the current study, an 
upper limb subscore of the UPDRS-III improved in only the RATE group.  Since 
treadmill walking minimally involves the upper limbs, the transfer of motor symptom 
improvement to the upper limbs may be indicative of improvements in basal ganglia 
functioning resulting from exercise. It is proposed that the rapid and rhythmic pulses 
of somatosensory feedback generated from high cadence exercise may be interacting 
with the basal ganglia, and recovering its ability to control motor output.  
The exact mechanism explaining how a high rate of somatosensory feedback 
improves the motor symptoms of PD remains unclear. However, the high frequency 
of rhythmic afferent feedback generated from high cadence exercise may act as a 
pacemaker and perturb the abnormal rhythms that have been reported to occur within 
the Parkinsonian basal ganglia (Brown et al., 2001; Marsden, Limousin-Dowsey, 
Ashby, Pollak & Brown, 2001). These abnormal oscillatory rhythms recorded from 
the subthalamic nucleus are prominent in the 20 Hz range, or the “beta band” (Brown, 
2001).  This spike in beta band frequency is not present in healthy subjects, is 
attenuated by dopaminergic medication and deep brain stimulation, and lastly 
correlates to bradykinesia and rigidity based motor symptoms (Kuhn et al., 2006; 
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Kuhn et al., 2008; Kuhn et al., 2009).  This pacemaker effect is plausible because 
input from the mechanoreceptors propagates up the medial lemniscus pathway which 
interacts with the thalamus; the relay centre for the basal ganglia.  After repeated high 
cadence exercise sessions, the abnormal spike in beta band frequencies that occur 
during movement in PD may be altered by the fast rate of somatosensory feedback 
that high cadence exercise generates.  Although further research would be needed to 
confirm this hypothesis, it is proposed that the somatosensory feedback generated 
from high cadence exercise may adjust the abnormal oscillatory rhythms within the 
basal ganglia in a manner similar to dopaminergic medication and deep brain 
stimulation, provoking long lasting therapeutic effects as a result.    
The MAGNITUDE group was included in the study in an effort to examine 
the therapeutic effects of another variant of somatosensory feedback during treadmill 
walking.  However, instead of altering the rate at which the somatosensory feedback 
is being generated, the ankle weights were intended to elicit a response greater in 
magnitude from tension sensitive golgi tendon organs in the lower limbs of the 
participant.  The rationale for including this somatosensory feedback manipulation 
was to emulate the feedback that exercise interventions such as strength training, Tai 
Chi, and PD SAFEx generate.  The aforementioned exercises involve aspects of slow, 
load bearing movements (a lunge in PD SAFEx or Tai Chi, and resistance training in 
general). Although these exercises differ from each other, they all generate a similar 
type of somatosensory feedback which is greater in magnitude, particularly from 
tension sensitive GTO’s.  Although the exact mechanism leading to the therapeutic 
benefit of these body awareness exercises is unknown, the feedback from tension 
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sensitive GTO’s may aid in the participant’s ability to properly attend to their 
movements, as the increased output of afferent signaling may help overcome the 
proprioceptive deficits reported in PD (Khudados, Cody & O’Boyle, 2009; Rickards 
& Cody, 2007). Thus, the hypothesis was that if a greater afferent signal from 
somatosensory receptors into the central nervous system contributes to the therapeutic 
effects reported from these types of exercises, then the MAGNITUDE condition 
would show improvements in the UPDRS-III in the current study.  However, in the 
current study UPDRS-III scores for the MAGNITUDE group did not significantly 
improve at post-test, implying that a greater magnitude of somatosensory feedback 
may not be as therapeutic as a high rate of feedback.  Furthermore, the therapeutic 
benefits generated from slower, load bearing exercise interventions may not be reliant 
on the magnitude of somatosensory feedback they generate, but rather other factors. 
For instance, in resistance based exercise, repetitive training sessions have been 
reported to increase cortical excitability in healthy controls (Kidgell, Stokes, 
Castricum & Pearce, 2010), a measure that has been reported to be worse in a 
Parkinsonian population and in part responsible for the pathology of the disease 
(Valls-Sole, Pascual-Leone, Brasil-Neto, Cammarota, McShane & Hallett, 1994).  
Improvements in postural control and gait from Tai Chi have been attributed to 
improvements in muscular strength of the lower limbs, while mechanisms responsible 
for upper limb motor symptom relief in these studies still remain unclear (Li et al., 
2012). Further research is needed to understand the mechanism responsible for 
improvements in motor symptoms of PD reported in body awareness based exercises.  
Body weight support during treadmill training 
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 The use of body weight support (BWS) during treadmill originally arose from 
gait training studies in stroke populations whose motor impairments were too severe 
to walk without the aid of an assistive device.  Their application was then adapted for 
use in the Parkinsonian population, who similarly may have motor disabilities 
preventing them from achieving and maintaining an intensity of exercise necessary 
for motor symptom improvement. Miyai et al. (2000) were the first to employ the use 
of BWS in a Parkinsonian population. Their 6 week program yielded a significant 3.2 
point improvement in UPDRS-III.  Their study did not report cadence or average 
speed at which the participants trained at, but did mention that the maximum training 
speed was 3.0 km/h.  The greater 4.5 point improvement in UPDRS-III that the 
RATE group reported in the current study reported program was likely due to the 
participants walking at a faster velocity (5.63 km/h in the RATE group) and more 
importantly, with a more rapid cadence which generates a higher rate of 
somatosensory feedback. Interestingly, in the current study, the MAGNITUDE and 
CONTROL conditions were fairly similar to the Miyai intervention which reported 
significant improvements in UPDRS-III. However, an important difference between 
ours and Miyai’s study was that UPDRS-III assessments in the Miyai study were 
performed by an assessor who was not blinded to group assignment. Lastly, in the 
Miyai study, the standard deviations about the means at pre and post were 
considerably smaller than in the current study (1.2 in Miyai compared to 6.93 in 
MAGNITUDE and 8.64 in CONTROL). Less interindividual variability may have 
facilitated the finding of a statistical difference between pre and post tests.  
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  The use of BWS in the current study was employed to have the ability to 
adapt treadmill exercise to a wider spectrum of locomotor and balance disability. This 
was especially important for the high cadence RATE group, as it is difficult to 
maintain a high cadence for an extended period of time without the aid of an assistive 
device, such as a harness.  Although it is beneficial to be able to adapt exercise to a 
wide variety of participants, the use of BWS may have been the reason for why there 
were no improvements reported in any of the balance measures.  It is proposed that 
the use of BWS minimizes the dynamic challenges faced by the participant to 
maintain balance during gait, explaining why no improvements in balance were 
reported.  It is proposed that future studies employing treadmill training within PD or 
other disabled populations still take advantage of BWS to adapt the exercise to the 
ability of the participant. However, the minimum amount of BWS required to achieve 
and maintain a proper gait pattern should be used to still allow the balance and 
postural control of the participant to be challenged.  
Additional Outcome Measures 
Additional measures that examined upper limb motor function were included 
within the assessment battery in an effort to examine if treadmill exercise, which is 
predominantly lower limb based, could lead to upper limb symptom improvement. 
Improvement in tasks completely unrelated to the exercise intervention may be 
indicative of a change in basal ganglia functioning compared to outcome measures 
similar to treadmill walking, such as spatiotemporal aspects of gait.  The UPDRS-III 
has a thorough upper limb section and is considered the gold standard for assessment 
of the motor symptoms of PD.  However, due to its subjective nature, has drawn 
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criticism for accuracy and validity. Due to this, objective measures to compliment the 
UPDRS-III are a valuable addition to the test battery.  
The Kinesia Homeview assessment mimics upper limb tasks from the 
UPDRS-III, but captures movement data from an accelerometer placed on the index 
finger of the participant. The results from the Kinesia Homeview showed a group by 
time interaction revealing an upper limb improvement in the MAGNITUDE group for 
the participants more affected limb, while RATE and CONTROL groups did not 
differ significantly.  This finding was surprising as it was in direct opposition to the 
results found from the upper limb sub score of the UPDRS-III, which showed 
improvement for the RATE group only.  This conflicting result may in part be 
explained by the MAGNITUDE group having a higher score at pre in the Kinesia 
(14.91, compared to 13.6 in the RATE group), while having a more closely matched 
UPDRS-UL score.  Although the objective nature of the Kinesia is appealing, 
research regarding its validity is still limited.  Existing research shows that the 
Kinesia system can accurately assess tremor (Giuffrida, Riley, Maddux & Heldman, 
2009) and bradykinesia (Heldman et al., 2011), however, its ability to emulate the 
other upper limb measures on the UPDRS-III is questionable.  For this reason, it is 
recommended to employ objective upper limb measures alongside of the Homeview 
system. 
In addition to the Homeview system, a 25 peg Lafayette instruments grooved 
pegboard (GP) was used as an additional outcome measure.  Previous work has 
shown that the “place” phase of the task correlates strongly with overall UPDRS-III 
motor scores (Sage, Bryden, Roy & Almeida, 2002).  In the current study, no 
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differences in any measures of the GP were reported as a result of the exercise 
program.  This is likely due to the high standard deviations around the mean values 
reported in the GP scores. High standard deviations arise from this task because 
participants with severe tremor are often severely challenged compared to those who 
are akinetic-rigid dominant. Despite converting values to a seconds per peg rate, the 
large variance of the data made it very difficult to discover an effect.  Although the 
test does correlate well to overall UPDRS-III scores, it is likely that it is not sensitive 
enough to detect changes in motor symptoms as a result of exercise.  Furthermore, 
issues with vision as well as arthritis in the hands may skew the results of this 
outcome measure, as it is influenced by non Parkinsonian ailments.  
Adverse Events 
 There were no major adverse events as a result of the current exercise 
program. Participants were required to return a PARmed-X with a physician’s 
approval which had an accurate description of the requirements of the program.  
There were 2 minor injuries as a result of the program, both of which occurred in the 
MAGNITUDE group.  One participant complained of slight hamstring stiffness, and 
the other developed minor back pain. Since both incidents occurred in the 
MAGNITUDE group, the ankle weights that this group wore may have contributed to 
their injuries.  No adverse cardiovascular events occurred as a result of the exercise 
program, likely due to the stringent exclusion criteria.  However, in future studies, it 
is recommended that participants perform a stress test in addition to a PARmed-x 
form to ensure that they are capable of tolerating aerobic exercise.   
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 Although not considered to be an adverse event, some participants complained 
about chronic fatigue towards the end of the program as a result of exercise.  An 
inherent difficulty with exercise studies is that participants may feel obliged to 
complete the program despite feeling fatigued.  In future studies, it is recommended 
that the lead researcher include a section in the informed consent emphasizing that 
rest days can be taken if needed.   
 Since no major adverse events occurred as a result of the exercise program, 
the improvements in UPDRS-III scores and spatiotemporal aspects of gait were worth 
the risk of participating in the study.   Of the 48 people that were initially enrolled in 
the program, only 2 experienced an adverse outcome.   
Limitations 
 Developing a suitable and effective exercise program for a PD population was 
a difficult endeavor to undertake.  A main issue that arose during the design of the 
study was the requisite to tailor and adapt this program to make it accessible for as 
wide of a disease spectrum as possible.  Unfortunately, due to the intense nature of 
the intervention, stringent exclusion criterion had to be applied to ensure that those in 
the program would be capable of performing the exercise properly, and more 
importantly, to ensure that no harm would arise from exercising intensely.  In general, 
the sample in the current study included those with mild to moderate PD with little to 
no gait impairments. This greatly limits the Parkinsonian population that was 
represented within this sample and suitable for this type of exercise.  Although BWS 
can be used to some extent to accommodate the program to those who are more 
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severe, most participants still found it very difficult to maintain a high cadence during 
gait.  In future, it is recommended that high cadence exercise (RATE condition) be 
performed on a bicycle, as there are currently mechanical devices that aid in the 
maintenance of high cadence pedaling, thus making it less effortful to maintain.  
 Another limitation was that the amount of BWS that each participant received 
per session was not recorded.  This leads to the possibility that the use of BWS in the 
current study was not equal between groups.  Although the data is not available, the 
RATE group anecdotally used a much greater amount of BWS than the other 
conditions in an effort to facilitate the maintenance of high cadence walking for an 
extended period of time.  However, since aerobic intensity was very closely matched 
between groups, it is still likely that groups performed a comparable amount of work.  
The main concern regarding a mismatch of BWS between groups has to do with the 
amount of load that is experienced during gait.  Since the magnitude of tension 
sensitive golgi tendon response was a main manipulation of the study, the varying 
amount of load that would be experienced is a possible confounder.  However, 
reporting the amount of BWS is a difficult task, as the amount is constantly changing 
due to the slippage of the harnessing system.  Constant, systematic adjustments would 
be required in order to report it accurately, as there is no recorded mean value 
available from the device.   
Another possible limitation has to do with the average heart rate data recorded 
during the training sessions.  Initially, it was proposed that all participants would 
wear a Polar heart rate strap for the collection of average heart rate data. 
Unfortunately, the harness that all participants wore made it impossible for the strap 
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to stay in place comfortably while providing accurate readings. In substitution for the 
Polar heart rate straps, the pulse sensitive handles of the treadmill were used.  
Unfortunately, there have been no studies published that have examined the accuracy 
of the heart rate monitors on the Biodex Gait Trainer treadmill.  A separate issue 
regarding the average heart rate statistic is the use of beta blocking medication that is 
common in this population.  The use of this medication stunts the response of heart 
rate from exercise, making it challenging to receive accurate heart rate readings.  
Furthermore, autonomic system dysfunction particularly in the sympathetic division 
is common in PD populations and may contribute to inaccurate heart rate readings 
(Micieli, Tosi, Marcheselli & Cavallini, 2003). In future, to ensure that groups are 
appropriately matched, it is recommended that a measure of how much work is 
performed is recorded alongside of heart rate. Additionally, a measure of perceived 
exertion may be another valuable metric, as it can be indicative of heart rate as well 
as blood lactate levels. (Borg, Hassmen & Lagerstrom, 1987).  Alternatively, the 
generation of an individualized maximum heart rate from a maximal exercise test 
prior to training would allow for an accurate average heart rate.  However, this test 
requires an extended bout of maximal exercise which is likely not feasible in this 
population. Issues with heart rate accuracy lead to the possibility that groups did not 
train at matched aerobic intensities, introducing a possible confounder explaining 
differences between groups.  
 Lastly, it is questionable whether or not the somatosensory feedback 
generated in the MAGNITUDE group was truly representative of the feedback that is 
generated in the exercise programs that it was meant to emulate.  The additional 
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muscle tension from the ankle weights would only elicit a greater golgi tendon 
response from the extensors at the hip and knee.  The limited stretch response may 
not have been widespread enough to accurately represent the kind of somatosensory 
feedback generated by Tai Chi, PD SAFEx and strength training.  These types of 
exercises, especially Tai Chi and PD SAFEx, receive increased somatosensory input 
from the legs, trunk, and arms. The gap in somatosensory feedback generated in the 
MAGNITUDE group compared to that of the exercises it was meant to emulate may 
be a reason why the group did not improve UPDRS-III scores significantly. A 
possible method to make the somatosensory feedback more widespread would have 
been to apply weights to the wrists of the participants in the MAGNITUDE group.   
 
Conclusion 
 Despite the limitations of the study, valuable findings in regards to 
somatosensory feedback and its therapeutic contributions to exercise were 
discovered. The high cadence RATE group proved to be the most effective for motor 
symptom improvement, leading to the conclusion that exercise that generates a high 
rate of somatosensory feedback likely has a greater therapeutic potential. This finding 
stresses the importance of considering the somatosensory feedback that exercise 
generates when developing exercise programs for those with PD.  Specifically, those 
incorporating aerobic exercise into their routines should focus on maintaining a high 
cadence, whether the exercise is being performed on a bicycle or treadmill.  High 
cadence exercise can easily be adapted on a bicycle by using a lower gear with 
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minimal resistance, or on treadmill by using BWS.   In regards to the actual aerobic 
intensity, a Karvonen based MHR (220-age) should be around 60-70%.  This is 
supported by the current study, as well as the Ridgel et al. forced exercise programs 
that this study was inspired by.  
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